Panitumumab (Vectibix)
Panitumumab
Amgen south africa (pty)ltd
Registration
- Applicant
- Amgen south africa (pty)ltd
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Vectibix 5 ML EACH 5,0 ml VIAL CONTAINS PANITUMUMAB 100,0 mg | 5 ml | 44011044/30.1/0110 | Registered | Not determined | None |
| Vectibix 10 ML EACH 10,0 ml VIAL CONTAINS PANITUMUMAB 200,0 mg | 10 ml | 44011144/30.1/0111 | Registered | Not determined | None |
| Vectibix 20 ML EACH 20,0 ml VIAL CONTAINS PANITUMUMAB 400,0 mg | 20 ml | 44011244/30.1/0112 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.